FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Leon, Doraliz	en_US
dc.date.accessioned	2012-07-06T21:39:51Z
dc.date.issued	2003	en_US
dc.identifier.citation	FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans (2003 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965598
dc.description.abstract	This paper is a description of tissue-engineered products, their potential for replacing conventional approaches to missing or failing tissues and organs, and FDAâ€™s ongoing efforts to develop a comprehensive and uniform scheme for regulating them.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	prosthetics	en
dc.subject	prosthesis	en
dc.subject	artificial organs	en
dc.subject	replacement parts	en
dc.title	FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T21:39:51Z